8-K
Current Report
ArriVent BioPharma, Inc. Filed Acc 0001104659-26-076352
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading tm2618466d1_8k.htm…